Explore By Subject Area   

Immuno-Oncology 360°

Date: Feb 27, 2024 - Feb 29, 2024

Location: Brooklyn, NY

Testimonials

image placeholder

"IO360 was such a great opportunity to see good friends, learn of new and merging data, and get fresh perspectives from a full spectrum of stakeholders that give it the name."

- Dr James Gulley, National Cancer Institute

"Congratulations again on the excellent program for the Immuno-Oncology 360° meeting. It was truly well coordinated and the topics were fantastic!"
​​​​​​​

- Dr Gilson Baia,  Champions Oncology

"IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"

​​​​​​​- Jim Mansfield, PerkinElmer

image placeholder

"Thank you again for the amazing invitation, it was truly my pleasure to be able to participate in the excellent event you organized."
​​​​​​​

​​​​​​​- Dr Christine Ward, BMS 
​​​​​​​

"Really good, well-rounded and novel content. Congratulations on filling the house beyond capacity and for securing such an ​​​​​​impressive speaking faculty."

- Eileen Daniels, Nektar Therapeutics

"The conference was informative on many fronts; not just scientific progress but also with Big Pharma vs small bio perspective and the investment community. I really enjoyed the Women's Luncheon to hear different perspectives from women leaders in our field."

- Laura Agensky, CUE Biopharma

image placeholder

"The breadth and depth of this IO dedicated meeting is just unmatched, and it becomes better year after year. Kudos."

-Dr Samuel Zhang, Gracell Biotechnologies

"Excellent speakers, diverse topics and good perspectives."

- Scott Turner, Pliant Therapeutics

"Your team did a wonderful job in putting together an interesting and relevant program."

- Lew Bender, Intensity Therapeutics

image placeholder

"I really enjoyed it and connecting with some really interesting and inspiring people with whom I'm sure this is just the beginning of long standing interactions."

- Jacqueline Karmel, Roche

"Nice mixture of large pharma and smaller drug discovery companies."

- Spencer Eggen, Bruker

2024 Sponsors

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.